Ysios Capital — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

BioClin Therapeutics inMay 2018

BiotechSan Leandro, US

Steve Abella(Chief Medical Officer)inGraeme Currie(Chief Operating Officer)in Stephen W. Lau(President, Chief Executive Officer, and Treasurer)in Kenneth Schwartz(Executive Officer)in Eric Yuen(Executive Officer)in Marten Steen(Director)in

Co-investorsHealthCap Inkef Sectoral Asset Management Sofinnova Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Galecto

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.